Join to View Full Profile
1901 S 2nd StMcAllen, TX 78503
Phone+1 956-687-5150
Fax+1 956-687-9546
Are you Dr. Restrepo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alvaro Restrepo, MD is an oncologist in McAllen, Texas. He is currently licensed to practice medicine in Texas and Florida.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1997- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1991 - 1993
Institute of Health Sciences Medellin Faculty of MedicineClass of 1987
Certifications & Licensure
FL State Medical License 1992 - 2027
TX State Medical License 2001 - 2025
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens.Azadeh Nasrazadani, Juan Luis Gomez Marti, Kate Lathrop, Alvaro Restrepo, Szu-Yun Leu
Breast Cancer Research and Treatment. 2024-05-01 - 16 citationsEflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.Lee S. Schwartzberg, Gajanan Bhat, Julio Antonio Peguero, Richy Agajanian, Jayaram S. Bharadwaj
The Oncologist. 2020-08-01 - 5 citationsKaposi sarcoma incidence in females is nearly four-fold higher in the Lower Rio Grande Valley compared to the Texas averageWendy Innis-Whitehouse, Xiaohui Wang, Nicolas Restrepo, Carlos Salas, Katia Moreno
Cancer Treatment and Research Communications. 2018-01-01
Press Mentions
Two-Time Breast Cancer Survivor Shares Importance of MammogramsOctober 28th, 2021- Convince Me: Why Should I Participate in a Clinical Trial?June 12th, 2018
